Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001379929 | SCV001577830 | likely pathogenic | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2020-05-20 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg1264 amino acid residue in RTEL1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 25047097, 23453664, 24009516, 25099625, 26025130, 24009516, 25620558). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has not been reported in the literature in individuals with RTEL1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a frameshift in the RTEL1 gene (p.Gln1263Serfs*101). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 38 amino acids of the RTEL1 protein and extend the protein by an additional 62 amino acids. |